Lim JK, Gibson AE, He J, Antonucci A, et al. Tracking Utilization of Neoadjuvant Endocrine Therapy (NET) and Neoadjuvant Chemotherapy (NCT) for Hormone Receptor-Positive Breast Cancer (HR + BC) in the U.S.A. Over Time - A TriNetX Database Study. Clin Breast Cancer 2026;26:39-45.
PMID: 42314607